Roche Signs US$2 B Partnership with Monte Rosa for Molecular Glue Medicines

By Amit Kaushik

Pharma Deals Review: Vol 2023 Issue 10 (Table of Contents)

Published: 30 Oct-2023

DOI: 10.3833/pdr.v2023.i10.2829     ISSN: 1756-7874

Section: Research & Development



In yet another deal to diversify its portfolio, Roche has entered into a licensing and collaboration agreement with Monte Rosa Therapeutics to develop small molecule-based therapeutics for challenging targets in major disease areas, including oncology and neurodegeneration...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details